E. Agardh

707 citations

18 papers · 550 indexed · h-index 12

Impact in

Ophthalmology top 2%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
Clinical Biochemistry top 5%
- Advanced Glycation End Products research

Papers in

Ophthalmology 12
- Retinal Diseases and Treatments 12
- Glaucoma and retinal disorders 4
- Retinal and Optic Conditions 2
Clinical Biochemistry 5
- Advanced Glycation End Products research 3
- Metabolism and Genetic Disorders 2

Co-authors: C.-D. Agardh Björn Hultberg Anders Andersson C.–D. Agardh Ole Torffvit C.‐D. AGARDH Bo Israelsson Anders Isaksson
Journals: Diabetologia (4 papers)Scandinavian Journal of Clinical and Laboratory Investigation (3 papers)Diabetic Medicine (2 papers)Journal of Internal Medicine (2 papers)Journal of Diabetes and its Complications (1 paper)
Partner nations: Sweden United States Australia

In The Last Decade

E. Agardh

18 papers receiving 522 citations

Peers

Countries citing papers authored by E. Agardh

Since Specialization

Citations

This map shows the geographic impact of E. Agardh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Agardh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Agardh more than expected).

Fields of papers citing papers by E. Agardh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Agardh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Agardh. The network helps show where E. Agardh may publish in the future.

Co-authors

The 25 scholars most cited alongside E. Agardh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Agardh Line = papers co-authored together E. Agardh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	The −374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients Diabetologia ·Eero Lindholm, E. Bakhtadze, Magnus Sjögren, Corrado Cilio, E. Agardh, Leif Groop, C.-D. Agardh	2006	56
2	Visual acuity and perimetry as measures of visual function in diabetic macular oedema Diabetologia ·E. Agardh, BARBACIORU Iuliana Carmen, Anders Heijl, Bo Bengtsson	2005	15
3	Circulating anti-pericyte autoantibodies are present in Type 2 diabetic patients and are associated with non-proliferative retinopathy Diabetologia ·Coronel Rafael David Sánchez Gómez, C.-D. Agardh, Magnum Augusto Moraes Lopes de Jesus, BARBACIORU Iuliana Carmen, 邓岗西, E. Agardh	2003	18
4	Diabetes duration may modify the association between genetic variation in the glycoprotein Ia subunit of the platelet collagen receptor and risk of severe diabetic retinopathy: a working hypothesis Thrombosis and Haemostasis ·E. Agardh, Gayle Teramura, 小麻里上野, Lakshmi K. Gaur, Upendra Kasthurirengan, Alexander P. Reiner	2003	5
5	Contrast sensitivity and visual recovery time in diabetic patients treated with panretinal photocoagulation Acta Ophthalmologica Scandinavica ·総一郎横田, Z. Greaves, E. Agardh	2000	20
6	Long-standing hyperglycemia in C57BL/6J mice does not affect retinal glutathione levels or endothelial/pericyte ratio in retinal capillaries Journal of Diabetes and its Complications ·Carl‐David Agardh, E. Agardh, Björn Hultberg, Bo Åhrén	2000	10
7	Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats Current Eye Research ·E. Agardh, Björn Hultberg, C.-D. Agardh	2000	62
8	Retinal examination intervals in diabetic patients on diet treatment only Acta Ophthalmologica Scandinavica ·M. Hossein Nosrat, E. Agardh, C.–D. Agardh	1997	7
9	HLA-DQB1 * 0201/0302 is associated with severe retinopathy in patients with IDDM Diabetologia ·Daniel Agardh, Lakshmi K. Gaur, E. Agardh, Mona Landin‐Olsson, C.–D. Agardh, Åke Lernmark	1996	43
10	Plasma β-hexosaminidase isoenzymes a and B exhibit different relations to blood glucose levels in a population of Type 1 diabetic patients Scandinavian Journal of Clinical and Laboratory Investigation ·Björn Hultberg, Aleksander S. Kaledin, E. Agardh, C.-D. Agardh	1995	6
11	A 5‐year follow‐up study on the incidence of retinopathy in type 1 diabetes mellitus in relation to medical risk indicators Journal of Internal Medicine ·E. Agardh, C.–D. Agardh, Ole Torffvit	1994	9
12	A Four‐year Follow‐up Study on the Incidence of Diabetic Retinopathy in Older Onset Diabetes Mellitus Diabetic Medicine ·E. Agardh, C.‐D. AGARDH, Sasha Koul, Ole Torffvit	1994	32
13	Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitus Scandinavian Journal of Clinical and Laboratory Investigation ·C.–D. Agardh, E. Agardh, Anders Andersson, Björn Hultberg	1994	78
14	Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus Scandinavian Journal of Clinical and Laboratory Investigation ·B. Hultberg, E. Agardh, Anders Andersson, Lars Brattström, Anders Isaksson, Bo Israelsson, C.-D. Agardh	1991	116
15	The prevalence of retinopathy and associated medical risk factors in type I (insulin‐dependent) diabetes mellitus Journal of Internal Medicine ·E. Agardh, Ole Torffvit, C.‐D. AGARDH	1989	32
16	Putative Risk Factors Associated with Retinopathy in Patients with Diabetes Diagnosed at or after 30 Years of Age Diabetic Medicine ·E. Agardh, Ole Torffvit, C.‐D. AGARDH	1989	18
17	Plasma Lipids and Plasma Lipoproteins in Diabetics with and without Proliferative Retinopathy Acta Medica Scandinavica ·C.‐D. AGARDH, E. Agardh, Birgitta Bauer, Peter Nilsson‐Ehle	1988	8
18	γ-Aminobutyric acid-mediated inhibition at cholinergic synapses formed by cultured retinal neurons Brain Research ·E. Agardh, Hermes H. Yeh, Roland Herrmann, Donald G. Puro	1985	15

About E. Agardh

E. Agardh is a scholar working on Ophthalmology, Clinical Biochemistry, Physiology, Radiology, Nuclear Medicine and Imaging and Rheumatology, having authored 18 papers that have together received 550 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (12 papers), Retinal Imaging and Analysis (8 papers), Glaucoma and retinal disorders (4 papers), Adenosine and Purinergic Signaling (3 papers), Advanced Glycation End Products research (3 papers), Retinal and Optic Conditions (2 papers), Diabetes and associated disorders (2 papers) and Metabolism and Genetic Disorders (2 papers). The work is most often cited by research in Ophthalmology (204 citations), Clinical Biochemistry (129 citations), Rheumatology (179 citations), Nephrology (52 citations) and Obstetrics and Gynecology (50 citations). E. Agardh has collaborated with scholars based in Sweden, United States and Australia. Frequent co-authors include C.-D. Agardh, Björn Hultberg, Anders Andersson, C.–D. Agardh, Ole Torffvit, C.‐D. AGARDH, Bo Israelsson, Anders Isaksson, B. Hultberg and Lars Brattström. Their work appears in journals such as Diabetologia, Scandinavian Journal of Clinical and Laboratory Investigation, Diabetic Medicine, Journal of Internal Medicine and Journal of Diabetes and its Complications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact